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ABSTRACT
The incomplete healing of articular cartilage defects is a common orthopaedic
problem. Articular cartilage does not heal spontaneously and untreated lesions may
progress to osteoarthritic degeneration. Consequently, a number of clinicians and
researchers are committed to developing new methods to induce healing of chondral
defects. With the emphasis on the effects of treatments on the cartilage defect, potential
changes in the surrounding tissue have not yet been addressed.
This study utilizes a canine model to quantify changes that occur in articular
cartilage fifteen to eighteen weeks after a knee joint is subjected to surgical treatment of
isolated chondral defects. Clinical and experimental treatment of articular cartilage
defects may include implantation of matrix materials and/or cells. The techniques
evaluated here include four methods involved in the treatment of articular cartilage
defects (microfracture, microfracture plus implantation of a type II collagen matrix,
implantation of an autologous chondrocyte-seeded collagen matrix, and the harvest of
trochlear ridge articular cartilage to obtain cells for the cell-seeded procedure).
Physical properties (thickness, equilibrium compressive modulus, dynamic
compressive stiffness, and streaming potential) and biochemical composition (hydration,
GAG content, DNA content) of the cartilage from various sites in these joints were
compared to values measured for site-matched controls in unoperated knee joints. A
number of significant changes were noted, with the patellar groove sites in the harvest-
operated knees displaying up to three-fold increases in cartilage dynamic stiffness and
streaming potential.
It is unknown whether or not the changes reported here will lead to osteoarthritic
degeneration, but this study provides evidence that surgical treatment of chondral defects
may elicit changes in the articular cartilage distant to the site being treated. Furthermore,
treatment protocols that induce further trauma to the joint surface may lead to more
severe changes.
Thesis Supervisor: Myron Spector
Title: Senior Lecturer, Department of Mechanical Engineering
Professor of Orthopaedic Surgery (Biomaterials), Harvard Medical School
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CHAPTER 1: INTRODUCTION
1.1. Purpose of Research
Focal lesions in articular cartilage may arise from traumatic injury or disease.
Healing of such lesions in adults is very limited and over time, the focal lesions may
progress to osteoarthritis. In an effort to minimize the patient's risk for developing
osteoarthritis, surgeons have developed a number of surgical techniques aimed at
repairing articular cartilage defects (Minas and Nehrer, 1997). While the current
procedures may achieve the goals of relieving pain and restoring function for many
patients, they fail to provide full regeneration of articular cartilage. These procedures
range from minimally invasive arthroscopic procedures to complex, open-joint
operations. As scientists and clinicians continue to search for more effective methods for
treating articular cartilage defects, the effects that different treatments have on the rest of
joint becomes a compelling issue.
This thesis evaluates the effects of four different surgical procedures, developed
to repair articular cartilage defects, on the articular cartilage throughout the rest of the
joint. By quantifying changes in mechanical and biochemical properties induced by the
four surgical procedures, this thesis also aims to determine if certain procedures may
have the potential to be more detrimental to the joint than others.
1.2. Background
Articular cartilage is the aneural, avascular hyaline cartilage layer covering the
bone ends at the articulating surface of diarthroidal joints. Chondrocytes are the
specialized cells that are responsible for maintaining the cartilage matrix. In skeletally
mature animals, chondrocytes are sparsely distributed throughout the matrix (roughly
10,000 cells/mm3 in adult human femoral head cartilage; Venn and Maroudas, 1977) and
are characterized by low mitotic activity.
Healthy articular cartilage functions to: 1) protect bones from abrasion and
damage, 2) transmit and distribute high compressive loads to the bone, 3) provide joint
congruity and maintain low contact stresses, and 4) provide a smooth, lubricated surface
for joint articulation. The articular cartilage matrix that serves these functions is
composed predominantly of water (65-75% of the total weight), type II collagen (50-90%
of the dry weight) and charged proteoglycans (5-10% of the dry weight).
1.2.1 Mechanical Properties of Articular Cartilage
The low hydraulic permeability and high swelling tendency of the proteoglycan-
rich network coupled with the tensile resistance of the collagen network give rise to the
characteristic mechanical properties of articular cartilage, in particular the high
compressive modulus and streaming potential. During compression, the swelling
pressure, created by charge repulsion of the ionized proteoglycan molecules, resists
deformation of articular cartilage. Deformation is further resisted by the tensile strength
of the collagen fibers. Changes in either the collagen organization or proteoglycan
content are reflected in changes in the compressive modulus of the tissue (Guilak et al.,
1994; Hoch et al., 1983).
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As articular cartilage is deformed, the mechanical pressure forces water out of the
matrix. This time-dependent fluid exudation through the fixed charge network gives rise
to an electric streaming potential. The magnitude of the streaming potential in response
to dynamic compression is a sensitive measure of cartilage integrity and can detect
changes in the tissue before changes are seen histologically or by standard mechanical
tests (Bonassar et al., 1995; Hoch et al., 1983).
1.2.2 Natural Healing of Articular Cartilage
The avascularity and relative acellularity of adult articular cartilage results in a
very limited capacity for natural repair. Partial thickness defects (ie: those restricted to
the cartilage layer), in which no blood enters the wound, do not undergo any repair and
may remain empty indefinitely (Mankin, 1982). Full-thickness defects that violate the
subchondral bone can become partially filled with repair tissue (Mankin, 1982; Minas et
al., 1997) arising from the blood, marrow, and bone cells infiltrating the defect from the
underlying, vascularized osseous tissue. The repair tissue, however, tends to be fibrous
or fibrocartilaginous tissue, consisting predominately of type I instead of type II collagen.
Although there may be some maturation of the repair tissue towards hyaline cartilage,
maturation is incomplete and the repair tissue eventually begins to deteriorate (Minas et
al., 1997).
1.2.3 Factors Affecting Cartilage Degradation
It is unclear which factors lead to degradation of articular cartilage. Enzymes,
such as collagenases and aggrecanases, and regulators, such as IL-1, TNF-ot, and various
metalloproteinases, can all contribute to the breakdown of the articular cartilage matrix
(Dodge and Poole, 1989; Imai et al., 1997; Lohmander et al., 1993; Pettipher et al., 1986;
Testa et al., 1994; Webb et al., 1997). These enzymes and regulators appear to be
released from chondrocytes and synovial membrane cells. For example, IL- 1 is released
by the cells in the synovial membrane as part of an inflammatory response and has been
linked to the loss of matrix proteoglycans (Bird et al., 1997; Pettipher et al., 1986).
Normal articular cartilage function depends on the low hydraulic permeability and
the hydrophilic nature of the proteoglycans and the tensile strength of the collagen fiber
network (Poole, 1992). Thus, changes in proteoglycan and/or collagen content will lead
to altered loading of the articular cartilage and underlying bone. Altered loading may
further lead to erosion and degradative changes in the cartilage, due to the metabolic
response of chondrocytes to changes in mechanical loads and the positive feedback to the
cells responsible for the initial release of enzymes and regulators (Poole, 1992).
1.2.4 Cartilage Repair Procedures
A number of surgical procedures have been developed and continue to be
investigated with the aim of promoting healing of articular cartilage defects (Minas et al.,
1997). Procedures that are currently used by orthopaedic surgeons to treat cartilage
defects range from arthroscopic procedures aimed at inducing bleeding from the
subchondral bone (ie: abrasion arthroplasty, microfracture), to open procedures that
involve implantation of cells (autologous cell implantation, ACI; Brittberg et al., 1994) or
bone-cartilage grafts (mosaicplasty).
More recently, tissue engineering approaches have been used to attempt
regeneration of articular cartilage in various animal models. Tissue engineering may
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involve natural or synthetic matrices, cells from various sources, and/or regulators (Lee
and Spector, 1998). One matrix studied as a potential candidate for improving articular
cartilage repair is a type II collagen-glycosaminoglycan porous sponge. This type of
matrix, both cell-seeded and unseeded has been studied in vitro and in vivo in a canine
model (Breinan, 1998; Nehrer et al., 1997).
1.2.5 Potential Hazards of Cartilage Repair Procedures
The effects of the various cartilage repair procedures on the rest of the joint have
not been studied. It has been documented that arthrotomy alone may induce changes in
the articular cartilage, but the effects appear to be short-lived (Havdrup and Telhag, 1978;
Havdrup and Telhag, 1980; Speer et al., 1990). More invasive procedures may lead to
more permanent effects by creating particulate debris, additional tissue damage and/or
inducing an inflammatory response. For example, the microfracture technique causes
trauma to the underlying subchondral bone and draws blood along with various cell types
and chemical regulators into the joint. Furthermore, the harvest procedures that are
necessary for ACI and mosaicplasty create new defects in previously healthy articular
cartilage. For the ACI procedure, slices of articular cartilage are harvested from the
patient's trochlear groove. Superficial defects, such as those created during this harvest
procedure, are even less likely to heal than full-thickness defects (Mankin, 1982) and
may even lead to osteoarthritic changes (Grande et al., 1989).
The introduction of a foreign matrix into the defect site may further lead to
changes in the surrounding articular cartilage. Potential problems arise from fixation of
the implant into the defect, the body's response to the implanted material, and the effects
of matrix degradation and the degradation by-products. For example, a common method
of fixing the matrices in the defects involves suturing of a flap over the defect site.
Breinan, et al, found that the suture tracts remained with no signs of healing one year
post-operatively (Breinan et al., 1997). Additionally, Messner and Gillquist reported that
implantation of synthetic matrices into defects led to an increase in surface irregularities
of articular cartilage throughout the treated joints (Messner and Gillquist, 1993).
1.3. Specific Aim and Hypotheses
The specific aim of this research was to determine how four specific surgical
procedures associated with articular cartilage repair affect the physical, biochemical and
histological properties of the articular cartilage distant to the affected sites. A canine
model was used to study the effects of three aspects of tissue engineering, matrix
implantation, cell implantation, and autologous cell harvest. The three repair procedures
investigated in this study include a microfracture procedure as a control procedure that is
used clinically; microfracture and implantation of a porous type II collagen sponge to
study the effects of an analog extracellular matrix; and implantation of a type II collagen
sponge seeded with cultured autologous chondrocytes to study the effects of implanted
cells. Lastly, the effects of an associated articular cartilage harvest were studied to
determine the magnitude of damage induced when obtaining autologous cells.
The working hypothesis is that selected surgical procedures result in alterations in
the properties of articular cartilage throughout the joint. It is also hypothesized that more
invasive treatments may lead to greater changes.
9
CHAPTER 2: MATERIALS AND METHODS
2.1. Experimental Measurements
2.1.1 Physical properties
Articular cartilage is a load-bearing tissue. As it degrades, the ability of the tissue
to sustain and distribute loads decreases. To determine if the surgical procedures induced
such degradative changes, the equilibrium and dynamic stiffness of the articular cartilage
was measured at eight to ten sites in the joint. Dynamic stiffness was measured over a
range of frequencies as high frequency measurements are more sensitive to superficial
changes and lower frequency measurements reflect properties at deeper levels.
The water content of articular cartilage and the presence of charged proteoglycans
lead to compression-induced streaming potentials. These streaming potentials have
proven to be a sensitive indicator of cartilage degradation (Frank and Grodzinsky, 1987;
Frank and Grodzinsky, 1987; Frank et al., 1987) and were therefore measured at various
frequencies. Similar to the frequency dependence of dynamic stiffness, the streaming
potentials measured at high frequencies are reflective of the properties near the surface
while lower frequency measurements are influenced by the bulk.
Lastly, the thickness of the articular cartilage was measured. The thickness of the
articular cartilage can indicate tissue hypertrophy and degradation. Furthermore, the
exact tissue thickness was necessary to calculate the applied strain imposed on the tissue.
2.1.2 Biochemical composition
Early signs of cartilage degradation include increased water content and cell
necrosis (Bullough et al., 1985). The cellular response to mild degradation includes mild
increases in cellularity and increased synthesis of glycosaminoglycans (Bullough et al.,
1985). Thus, hydration, total GAG content, and DNA content were measured at seven
different sites in the joint and the values for the four surgical groups were compared with
site-matched the values measured for the unoperated control group.
2.1.3 Histology
The majority of previously published work on articular cartilage repair and
degradation has focused on the histological characteristics of the tissue. Major criteria
for grading degenerative articular cartilage are the concentration and distribution of
charged proteoglycans (Mankin et al., 1971). For this reason, articular cartilage was
prepared for staining with Safranin-O so that meaningful changes in proteoglycan could
be analyzed in a traditional manner (described in section 2.5.3).
It has recently been observed by other researchers in the laboratory (unpublished
data) that chondrocytes in the vicinity of articular cartilage defects contain the actin
isoform characteristic of smooth muscle cells and myofibroblasts (x-smooth muscle
actin, a-SMA). The role of a-SMA containing chondrocytes is not clear. Nonetheless,
in order to determine if chondrocytes distant to the defect also contained X-SMA,
selected specimens were prepared for immunohistochemical staining.
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2.2. Experimental Groups
2.2.1 Animals
Twelve adult (skeletally mature) hound dogs (25-30 kg) were used in this study.
The animal experiment was approved by the Brockton/West Roxbury VA Animal Care
Committee. Detailed descriptions of animal surgery and animal care are described
elsewhere (Breinan et al., 1997). Briefly, two 4-mm diameter defects down to the level
of the calcified cartilage were made in the trochlear groove of the right knees of all
twelve canines. Defects were then treated by one of three methods described below
(section 2.2.2). The right knees of all dogs were immobilized by external fixation for ten
days after surgery, after which the animals were allowed to ambulate freely. The animals
appeared to ambulate normally following removal of the external fixation. There was no
indication that the animals favored either hind limb.
2.2.2 Surgical Groups
The defects of eight of the dogs were subject to microfracture, a clinically used
technique in which the calcified cartilage was lightly scraped and a small pick was used
to puncture the subchondral bone and induce bleeding into the defect site. This was the
only treatment given to four of these dogs (microfracture group, gfx; n=4 dogs). The
other four dogs had porous type II collagen sponges (Chondrocell, Geistlich
Biomaterials, Wolhusen, Switzerland) implanted into the microfracture treated defects
(matrix group, n=4). The pore characteristics of the type II sponges have been described
previously (Nehrer et al., 1997). Type II collagen films were sutured over the defects to
secure the matrix in the defect. The film was produced from the same slurry used to
make the matrices and was cross-linked with ultraviolet radiation (Nehrer et al., 1997).
The defects in the remaining four dogs were treated with type II collagen sponges seeded
with cultured autologous chondrocytes (cell-seeded group, n=4). Implants were again
fixed in the defect by suturing a type II collagen film over the defect.
The chondrocytes used to seed the matrices in the cell-seeded group were
obtained from cartilage harvested from the contralateral (left) knees and expanded in
culture for three weeks prior to treatment of the defects. Cartilage was harvested from
the trochlear ridges by removing a strip of tissue approximately 20-25 mm long and 3-5
mm wide, down to the tidemark. This procedure yielded 300-350 mg (wet weight) of
tissue. The harvesting procedure was performed on five of the left knees (harvest group,
n=5), with the cells from one of the joints not being used. The left knees of the seven
remaining dogs were unoperated and served as controls (control group, n=7). It was not
anticipated that there would be any differences in tissue properties or composition
between right and left knees (Athanasiou et al., 1991).
2.3. Specimen Procurement and Allocation
Animals were sacrificed fifteen weeks after treatment of the defects (eighteen
weeks after the harvest procedure). Immediately after sacrifice, the knee joints were
opened under sterile conditions and the defect and harvest sites removed with a coping
saw for histomorphometric analysis (Breinan, 1998). The remaining portion of each joint
was then wrapped in saline-soaked gauze and transported from the operating room to the
laboratory.
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Eight sites on the right knee and ten sites on the left knee (Figure 2.1) were
identified for mechanical testing, yielding a total of 216 specimens. A custom made
coring bit, 9.5-mm internal diameter, fixed to a standard drill press was used to obtain
osteochondral cores from each identified site on the femur and from each tibial plateau.
The shaft of each long bone was clamped in a jig which allowed the rotation of the bone
so that the joint surface at each desired location could be positioned parallel to the cutting
edge of the coring bit. The joint surface and coring bit were kept moist throughout the
entire process with phosphate buffered saline (PBS). Prior to removal of the tibial cores,
the two testing sites (central and posterior) on each tibial core were marked with India
ink.
Opp 
PL 0C 
TT
CI CT
oPP
(DPG
ALF A F
o QF
P 0O F
Figure 2.1 - Schematic illustration of femur (left) and tibia (right) showing sites identified for mechanical
testing of articular cartilage. PLF=posterior lateral femoral condyle, ALF=anterior lateral femoral condyle,
PPG=proximal patellar groove, DPG=distal patellar groove, AMF=anterior medial femoral condyle,
PMF=posterior medial femoral condyle, CLT=central lateral tibial plateau, PLT=posterior lateral tibial
plateau, PMT=posterior medial tibial plateau, CMT=central medial tibial plateau. PPG and DPG sites
correspond to the defect sites in right knees which were removed for histomorphometric evaluation. PPG
and DPG sites were only tested in harvest and control knee joints. All sites except DPG, PMF, and PLF
sites were also analyzed for biochemical composition.
Osteochondral cores that were damaged during retrieval were discarded. The
remaining cores were immersed in PBS and frozen at -20 0C until the day of testing.
The articular cartilage and underlying bone surrounding the cores was placed in
10% neutral buffered formalin and processed for histological study.
2.4. Mechanical Testing
An indentation test protocol was employed, in part, in anticipation of future
studies of the mechanical properties of reparative tissue that would not be suitable for
confined compression testing. The indentation protocol was used to measure equilibrium
stiffness, dynamic stiffness, and streaming potential. Additionally, a needle-ramp method
was used to measure articular cartilage thickness.
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2.4.1 Testing Setup
2.4.1.1. Dynastat Mechanical Spectrometer
A Dynastat mechanical spectrometer (IMASS, Hingham, MA) was used to
perform mechanical testing. The Dynastat was connected to a computer that controlled
displacement of the actuator and recorded the resulting loads and potentials.
2.4.1.2. Indenter
The indenter used in this study was a 1-mm plane-ended plexiglass indenter
equipped with a 250-gm diameter Ag/AgC1 electrode. The electrode was used to
measure the compression-induced streaming potentials during sinusoidal compressions
(Lin et al., 1998).
2.4.1.3. Specimen Preparation
On the day of testing, osteochondral cores were thawed in phosphate buffered
saline with 10mM EDTA serving as a general proteinase inhibitor (PBE). The thawed
specimens were then mounted in self-curing polymethyl methacrylate (Quickmount,
Fulton Metallurgical Products Corp., Saxonburg, PA). Care was taken to mount only the
underlying bone in the Quickmount. Curing of the Quickmount took twenty to thirty
minutes. To minimize fluid loss during this time, the cartilage surface was covered with
tissue soaked in PBE. The mounted specimen was then placed in a plexiglass chamber
with five rotational/translational degrees of freedom or stored in PBE at 4"C until testing
was ready to commence. Specimens stored at 4"C were allowed to reach room
temperature prior to testing.
The plexiglass chamber was fixed in the lower jaw of the Dynastat and adjusted
so that the articular surface of the specimen was perpendicular to the axis of the indenter.
The chamber was then filled with PBE and the tissue allowed to equilibrate for ten
minutes and regain any fluid lost during the mounting and positioning process.
2.4.2 Stress Relaxation
Mechanical testing began with a tare load of approximately 0.01 kg to ensure
complete contact between the indenter and the cartilage. The cartilage was allowed to
relax under the tare load for five minutes.
To measure equilibrium behavior, stress relaxation tests at three different strain
levels were performed. Using displacement control of the Dynastat, three ramp and hold
displacements corresponding to approximately 10%, 15% and 20% strain (based on
estimated tissue thickness) were applied. The total time to achieve the desired
displacement was 180 seconds and the displacement was held for an additional 320
seconds. The load and displacement were continuously recorded. Load and
displacement measurements were then converted to stress and strain, using the area of the
indenter and the actual thickness of the tissue, as measured by the needle ramp method
described below (section 2.4.5). A stress relaxation curve for a typical specimen is
shown in Figure 2.2.
To determine the equilibrium compressive modulus, the equilibrium stress was
first plotted versus strain. A first order polynomial was fit to the stress-strain data and the
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slope of the line recorded. Using the analysis of Hayes, et al. (Hayes et al., 1972), an
effective equilibrium Young's modulus of the tissue was calculated from this slope,
Poisson's ratio (v), the aspect ratio (a/h; indenter radius/tissue thickness), and a tabulated
parameter (K, based on v and a/h; Hayes et al., 1972).
E = (o-E)(1-v 2)n(a/h)/2xK (1)
Figure 2.2 - Typical stress relaxation curve of articular cartilage during indentation ramp (0-180 seconds)
and hold (180-500 seconds) displacement.
Poisson's ratio for articular cartilage varies by species and site. We used values
reported for canine articular cartilage by Athanasiou (Athanasiou et al., 1991) for the
femoral sites and by Setton (Setton et al., 1994) for the tibial sites. These values ranged
from 0.05 for the tibial sites to 0.30 for the femoral condyles.
2.4.3 Dynamic Stiffness
Sinusoidal displacements with amplitudes of approximately 1 % strain and
frequencies of 1.0, 0.5, 0.1, 0.05, 0.01, and 0.005 Hz, were superimposed on the 15%
static strain. The resulting loads and displacements were recorded and converted to stress
and strain, respectively. Dynamic stiffness was then calculated as the ratio of stress to
strain. To account for differences in material stiffening due to differences in the applied
offset strain, as the tissue thickness was initially unknown, dynamic stiffness was
normalized to the static offset stress.
2.4.4 Streaming Potential
The streaming potentials generated by the sinusoidal displacements were detected
by the Ag/AgCl electrode in the probe and recorded by the computer. The potentials
were measured relative to the potential of the PBE bath and reported as voltage divided
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by dynamic strain amplitude. Again, to account for material stiffening, the streaming
potentials were normalized to the static offset stress.
2.4.5 Thickness Measurements
After mechanical testing, the indenter was removed and a needle probe was
clamped into the upper jaw of the Dynastat. A needle ramp method described by Hoch,
et al. (Hoch et al., 1983) was used to measure articular cartilage thickness at the site of
indentation testing. As the needle contacted the upper surface of the hydrated tissue, an
electrical circuit was completed, resulting in a step change in the voltage. When the
needle reached the underlying calcified cartilage, there was a step increase in the load.
These step changes were detected by computer analysis and the ramp rate and time
between step changes were used to determine the articular cartilage thickness.
2.5. Biochemical Analysis
Biochemical analysis was performed on seven of the ten sites identified for
mechanical testing. After mechanical testing and thickness measurements of these sites,
a scalpel was used to remove full-thickness slices of articular cartilage from half of the
plug. Care was taken to remove as much of the articular cartilage as possible without
removing any of the calcified cartilage. The slices of cartilage were weighed (section
2.5.1) and frozen for later biochemical analysis.
The remaining articular cartilage and subchondral bone was placed in 10% neutral
buffered formalin and processed for histology. For the three sites that were not subject to
biochemical analysis (distal patellar groove, posterior medial and lateral femoral
condyles), the entire plug was placed in formalin immediately after thickness
measurements were completed.
2.5.1 Hydration
Excess water was dried from the slices of removed cartilage and the wet weight of
the tissue measured. The slices of tissue were then frozen at -20'C. The frozen tissue
was later lyophilized for thirty to forty hours and dry weights measured. Hydration was
determined as follows:
hydration = (wet weight - dry weight)/dry weight (2)
2.5.2 Glycosaminoglycan Content
Lyophilized tissue was digested in 1.5-4 mls of papain (1.76 mg/ml cysteine,
0.125 mg/ml papain in PBE) for at least twelve hours at 60'C. Papain digests of the
tissue were analyzed for total glycosaminoglycan content using the DMMB dye binding
assay. A spectrophotometer (Perkin-Elmer Lambda 3b) measured absorbance at 525 nm.
Shark chondroitin-6-sulfate was used as the standard. Using the curve derived from the
standards, absorbance measurements were converted to GAG content.
2.5.3 DNA Content
Papain digests were also analyzed for DNA content using Hoechst 33528 dye
fluorescence. Fluorescence was measured on a spectrafluorometer (SPF-500c, SLM
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Instruments). To account for autofluorescence of the digests, fluorometer readings were
made both with and without Hoechst 33258 dye. Calf thymus DNA was used as the
standard. The DNA content was interpolated from the fluorometer measurements and the
standard curve.
2.6. Histology and Immunohistochemistry
Articular cartilage and underlying bone from areas around the tested cores were
allocated for histology on the day of animal sacrifice. The articular cartilage and
underlying bone from tested cores and not used for biochemical analysis was allocated
for histology after mechanical testing.
2.6.1 Fixation and Decalcification
Tissue allocated for histology was fixed in 10% neutral buffered formalin for five
to six days. After fixation, specimens were decalcified in 15% EDTA solution for at least
28 days.
2.6.2 Embedding and Sectioning
After fixation and decalcification, tissue was dehydrated through a series of
alcohol baths. Tissue was then embedded in either glycol methacrylate (JB-4,
Polysciences, Inc., Warrington, PA) or paraffin.
Select specimens were sectioned to five (JB-4 embedded specimens) or seven
(paraffin embedded specimens) micrometers in thickness.
2.6.3 Light Microscope Analysis
JB-4 sections were stained with Safranin-O/Fast Green. The Mankin scale
(Mankin et al., 1971) was used to make a semi-quantitative assessment of the degradative
changes of the tissue in the selected specimens. The Mankin scale grades cartilage
degradation based on cellularity (0-3 points), distribution of proteoglycan staining (0-5),
surface continuity (0-4), and integrity of the subchondral bone (0-1). The Mankin scale
ranges from 0-14, with normal articular cartilage scoring zero.
Immunohistochemistry was used to stain paraffin sections for the contractile
protein, a-smooth muscle actin, using a monoclonal antibody to the protein. Blood
vessels in the subchondral bone were used as positive controls and sections treated with
mouse serum instead of the monoclonal antibody served as the negative controls.
2.7. Statistical Analysis
2.7.1 Power Calculation of Sample Size
This study sought to identify changes in the mechanical and biochemical
properties of the surrounding articular cartilage that could potentially have a clinically
meaningful effect. That this was an initial investigation and conducted at a relatively
early time point (15-18 weeks post-operatively), it was anticipated that a change of 50%
would be compelling. Based on literature values for selected mechanical properties of
canine articular cartilage, we estimated a standard deviation of 25%. For a desired power
of 80% (0=0.20) and ac=0.05, a sample size of four was required.
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2.7.2 Statistical Analysis of Results
The measured properties at each site for each surgical group were compared to the
average values measured at the same site in the unoperated control group. An unpaired
Student's t-test assuming equal variances was performed on Excel. Statistical analysis
was also performed using the Fisher Exact test. After counting the number of occurences
of high and low values, the Fisher Exact test was performed using a program on the
Internet (http://www.nr.no/-langsrud/fisher.htm). The criterion for significance was
p<0.05, but changes with a p-value of less than 0.10 are also noted.
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CHAPTER 3:
3.1. Specimen Procurement
There was no indication that the animals favored either hind limb in the weeks
following surgery. In previous studies involving surgery (viz., total hip replacement) on
the hind limbs of dogs, quantitative gait analysis and analyzed computed tomography of
the tibias demonstrated that animals ambulating normally, as those in this study, applied
equal load bearing on the hind limbs.
At necropsy, there was no evidence of joint inflammation or gross abnormalities
in the articular cartilage distant from the defect and harvest sites. The defect and harvest
sites were easily identified at necropsy. Histomorphometric evaluation of the tissue
filling the original defects revealed predominately fibrocartilage in all of the defects
(Breinan, 1998).
A total of nine specimens were lost during specimen retrieval, leaving a total of
207 specimens for mechanical testing.
3.2. Physical Properties
Significant changes (p<0.05 by Student's t-test and/or Fisher Exact test), ranging
from 36 to 300% of control values were seen in the dynamic mechanical properties
(Table 3.1). These changes were seen at three sites in the harvest (DPG, PPG, and CLT)
and cell-seeded matrix (PLF, PMF, CLT) groups and at two sites in the matrix group
(CLT and PLT). At the p<O. 10 level, six of the ten sites in the harvest group, four of the
eight sites in the cell-seeded matrix and microfracture groups, and three of the eight sites
in the matrix group showed changes in at least one mechanical property. No changes
(p<0. 10) were seen in any treatment group at the CMT, ALF or AMF sites. All changes
in physical properties with p< 0 .10 are shown as percent changes from the (unoperated)
control values in Table 3.1.
3.2.1 Thickness
Articular cartilage thickness varied with site. Figure 3.1 shows how the mean
cartilage thickness in the unoperated (control) joints varied from site to site. The range of
values was from a low of 0.5 ± 0.05 mm (mean ± standard error of the mean) at the DPG
site to a high of 1.4 ±0.05 mm at the CMT.
Figure 3.2 shows how the articular cartilage thickness of the operated joints
compared to the thickness of the unoperated control joints. There were no significant
changes (p<0.05, by Student's t-test or Fisher Exact test) in cartilage thickness at any of
the sites between any of the operated groups and the unoperated control group. However,
there were a few sites where there were notable differences (p<O. 10) between operated
and unoperated groups (shown as percent changes in Table 3.1). The cartilage at the
DPG increased from an average thickness of 0.47 ± 0.05 mm in the control group to 0.63
0.03 mm in the harvest group, an increase of 33%. Other trends (pFshe included
decreases in tissue thickness at the PMF (thickness of control group 1.19 ± 0.07 mm) in
the matrix (1.01 ± 0.18 mm) and microfracture (1.10 ± 0.09 mm) groups; at the CLT in
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RESULTS
the matrix group (1.01 ± 0.12 mm versus 1.25 ± 0.10 mm for the control); and at the
PMT in the microfracture group (0.81 ± 0.20 mm versus 0.99 ± 0.07 mm for control).
Canine articular cartilage thickness at selected sites in unoperated joints. Values are mean ±
Figure 3.2 - Canine articular cartilage thickness at various sites in joints subjected to different surgical
procedures. Values are mean ± SEM (n=3-7).
3.2.2 Equilibrium Modulus
The effective equilibrium Young's modulus also varied by site (Figure 3.3). The
moduli for the unoperated joints ranged from 1.9 ± 0.1 MPa at the posterior lateral
femoral condyle to 3.7 ± 0.7 MPa at the DPG.
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Figure 3.4 shows how the equilibrium moduli for the different surgical groups
compare. Again, there were no changes between operated and unoperated groups that
reached a significance level of p<0.05 by the t-test. However, the modulus of the CLT
was significantly higher, by 37 ± 24%, in the cell-seeded matrix group compared to the
control group when analyzed with the Fisher exact test (p=0.024). At the p<0.10 level
(Fisher test), the moduli also tended to increase at the CLT in the microfracture group.
The moduli in the same three groups (harvest, cell-seeded matrix, and microfracture)
tended to decrease at the PLF (p<O. 10).
Figure 3.3 - Equilibrium compressive modulus of canine articular cartilage at selected sites in unoperated
knee joints. Values are mean ± SEM, n=6-7.
Figure 3.4 - Equilibrium compressive modulus of articular cartilage at various sites in joints subjected to
different surgical procedures. Values are mean ± SEM (n=3-7).
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3.2.3 Dynamic Stiffness
Dynamic stiffness was measured at six frequencies ranging from 0.005 to 1.0 Hz.
As shown in Figure 3.5, dynamic stiffness typically increased with increasing frequency.
The stiffness-frequency relationship illustrated in Figure 3.5 was similar for all sites and
surgical treatments tested. Thus for the purpose of comparing the effects of different
surgical treatments, the dynamic stiffnesses at 1.0 and 0.01 Hz for each specimen were
analyzed. Preliminary analysis indicated that, in general, if differences were seen at one
frequency, they were seen at all frequencies.
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Figure 3.5 - Dynamic stiffness versus frequency of applied displacement
the distal patellar groove (DPG) site in an unoperated knee.
for a canine articular cartilage at
The range of dynamic stiffness normalized to static offset stress seen in the
unoperated joints at 0.01 Hz (Figure 3.6a) was 22.4 ± 2.1 MPa/MPa (CMT) to 44.3 ± 3.5
MPa/MPa (PLF). At 1.0 Hz (Figure 3.6b), dynamic stiffness was again lowest at the
CMT (35.2 ± 3.9 MPa/MPa) and the highest dynamic stiffness at this frequency was at
the ALF (98.6 ± 19.5 MPa/MPa).
As illustrated in Figure 3.7, the tendency was for dynamic stiffness to be higher in
the operated groups versus the unoperated control. Differences in the dynamic stiffnesses
(compared to control) are summarized in Table 3.1.
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Figure 3.6 - Dynamic stiffness of canine articular cartilage at selected sites in unoperated knee joints (n=6-
7) measured at A: 0.01 Hz and B: 1.0 Hz. Values are mean ± SEM and normalized to static offset stress;
n=6-7.
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A
Figure 3.7 - Dynamic stiffness at A: 0.01 Hz and B: 1.0 Hz of articular cartilage at various sites in joints
subjected to different surgical procedures. Values are mean ± SEM and normalized to static offset stress
(n=3-7).
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3.2.4 Streaming Potential
Streaming potential measurements were made at the same six frequencies as
dynamic stiffness measurements. Figure 3.8 shows a typical relationship of streaming
potential and frequency. Again, since differences arising at one frequency were generally
seen at all frequencies, only the values at 1.0 and 0.01 Hz were normalized and analyzed
in detail.
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Figure 3.8 - Streaming potential versus frequency of applied displacement for a canine
at the distal patellar groove (DPG) site in an unoperated knee.
articular cartilage
As shown in Figure 3.9, the normalized streaming potentials of the control joints
was lowest at the PPG (0.58 ± 0.17 mV/MPa at 1.0 Hz, 0.38 ± 0.08 mV/MPa at 0.01 Hz)
and highest at the PLF (2.29 ± 0.20 mV/MPa at 1.0 Hz, 1.32 + 0.11 mV/MPa at 0.01 Hz).
In terms of magnitude of change and significance of change, the largest changes
between surgical groups and the control group were seen in the streaming potential
measurements (Figure 3.10). Again, the direction of change for streaming potential
measurements was an increase and three of the four surgical groups had at least one site
demonstrating a significant change. The largest change was an increase from 0.54 ± 0.11
mV/MPa (control) to 2.17 mV/MPa at the DPG site in the harvest group (p,-te=0.00l,
pFisher=0. 0 0 5 ). Significant changes and trends are summarized as percent changes from
control in Table 3.1.
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Figure 3.9 - Streaming potential of
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canine articular cartilage at selected sites in unoperated knee joints
B: 1.0 Hz. Values are mean ± SEM and normalized to static offset
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Table 3.1 - Changes in mechanical properties of canine knee articular cartilage following surgical
procedures (p<0.10). Changes are shown as group/site average percent changes (± standard error of the
mean) from the mean value measured at the same sites in unoperated joints.
changes reaching a significance of p<0.05.
Bold-faced values indicate
3.3. Biochemical Properties
The magnitude of the change in the biochemical properties was, in general,
smaller than in the mechanical properties. There were also fewer changes that reached
the p<0.05 and p<O.10 levels of significance (Table 3.2).
3.3.1 Hydration
In the control joints, the PPG had the lowest water content (hydration = 2.4 ± 0.1)
and the CMT had the highest water content (hydration = 4.2 ± 0.2; Figure 3.11).
There were not large variations in hydration among the different treatment groups
(Figure 3.12). The only site that appeared to be significantly affected by surgical
procedures was the AMF (hydration of control 2.5 ± 0.05). The harvest (2.9 ± 0.2),
matrix (2.8 ± 0.1) and microfracture (2.9 ± 0.1) groups all displayed a significant
(p<0.05) increase in hydration at this site (Table 3.2). This site in the cell-seeded matrix
group also had an increased water content (2.8 ± 0.3), but the increase did not reach
significance (PFisher 0 '0 6 )'
While the femoral sites tended to show increases in hydration for the surgical
groups compared to the control group, the tibial sites tended to show decreases in
hydration compared to the control group (Figure 3.12). None of these changes reached
significance (p<0.05), although some were notable. The matrix and microfracture groups
showed decreases of 12.9 ± 3.8% and 16.1 ± 6.2%, respectively, at the CMT site
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DynStf/StatStrs StrPot/StatStrs
Group Site Thickness Modulus 10.01 Hz 1.0 Hz 10.01 Hz 1.0 Hz
Harvest DPG 33 6 86 ±18 93 ±19 299 ±72 241 ±50
PPG 23 ±11 136 ±67 213 ±63
PLF -11 22 32 ±23 31 ±23
PMF 64 ±47 72 57
CLT 21 41 -17 11 -30 16
PLT 29 ±15 29 ±15
Cell+Matrix PLF -25 12 26 ± 16 47 18 37 11
PMF 47 8 58 ±11 86 20 89 21
CLT 37 24) 20 13 23 ±15 27 16 28 20
PMT 2 14
Matrix PMF -15 15
CLT -19 9 38±11 46 ±12 54 15 62 15
PLT 27 5 36 6 50± 9
Microfracture PLF -26 12
PMF -8 7 -25 ±7 -18± 4
CLT 21 41 34 22
PMT -19 20
(p.tC=0.071 and 0.053, respectively). Additionally, the PLT site in the cell-seeded matrix
group showed a decrease of 13.9 ± 6.8% (pFisher=0 0 8 8 )'
Figure 3.11 - Hydration of canine articular cartilage
mean ± SEM, n=6-7.
Figure 3.12 - Hydration of articular cartilage at various
procedures. Values are mean ± SEM (n=3-7).
at selected sites in unoperated knee joints. Values are
sites in joints subjected to different surgical
3.3.2 Glycosaminoglycan Content
As shown in Figure 3.13, the amount of GAG per dry weight of tissue for normal
articular cartilage ranged from 15.5 ± 0.8 gg/mg (ALF) to 29.0 ± 1.1 pg/mg (CMT).
There were not large variations in GAG content due to surgery Figure 3.14. The PMT
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was the only site that seemed to be affected by surgery. In the matrix group, the GAG
content at this site increased from 16.8 ± 0.9 jg/mg to 20.8 ± 1.3 gg/mg (p =0.029,
pFishr=0 .0 2 4 ). In the harvest group, the GAG content also tended to increase (20.5 ± 1.5
jg/mg; pt-tt=0 .0 5 6 ).
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Figure 3.13 - Total GAG content of canine articular cartilage at selected sites in unoperated knee joints.
Values normalized by tissue dry weight and presented as mean SEM, n=6-7.
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Figure 3.14 - Total GAG content of articular cartilage at
surgical procedures. Values are mean ± SEM (n=3-7).
various sites in joints subjected to different
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3.3.3 DNA Content
The PLT site in the control group had the highest DNA content per dry weight of
tissue (0.12 ± 0.008 jig/mg) and the CLT group had the lowest (0.053 ± 0.002 gg/mg)
(Figure 3.15). As shown in Figure 3.16, the CMT group in the harvest and cell-seeded
groups had significant increases (p<0.05) in DNA/dry weight. DNA content increased
from 0.065 ± 0.002 jg/mg to 0.079 ± 0.004 jg/mg and 0.077 ± 0.003 jig/mg,
respectively. The PMT group in the matrix group demonstrated a decrease of 22.4
3.4%, but this decrease was not significant (pt-e=0.07 8 , PFisher= 0 8 8 )'
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Figure 3.15 - Total DNA content of canine articular cartilage at selected sites in unoperated knee joints.
Values normalized by tissue dry weight and presented as mean SEM, n=6-7.
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Table 3.2 - Changes in biochemical composition of canine knee articular cartilage following surgical
procedures (p<0.10). Changes are shown as group/site average percent changes (± standard error of the
mean) from the mean value measured at the same sites in unoperated joints. Bold-faced values indicate
changes reaching a significance of p<0.05.
Group Site 1Hydration IGAG/dry IDNA/dry
Harvest AMF 15 6
CMT 20± 6
PMT 22 9
Cell+Matrix AMF 11 ± 11
PLT -14 7
CMT 17± 4
Matrix AMF 11 5 30 13
PLT 19± 6
CMT -13 4
PMT 24±8 -22± 3
Microfracture AMF 14 6 -2 ± 11
CMT -16 6
3.4. Histology and Immunohistochemistry
3.4.1 Safranin-O Staining
DPG sections were chosen for histological analysis because this site showed the
largest changes in mechanical properties. Histological sections verified that there was a
difference in articular cartilage thickness between the control and harvest groups (Figure
3.17). Safranin-O sections from DPG sites were graded for osteoarthritic degeneration
using the Mankin scale. All sections revealed intact bone-cartilage boundaries and had
no signs of fibrillation. Safranin-O staining intensity ranged from normal to slightly
decreased at the surface. Cellularity ranged from normal to slightly increased. Total
scores for graded histological sections ranged from zero to two (scale 0-14 with zero
being normal). No differences were seen in the scores from control and harvest groups.
3.4.2 x-Smooth Muscle Actin Staining
Immunohistochemical analysis was performed on selected specimens fixed both
on the day of sacrifice and on the day of testing. The smooth muscle cells of the
capillaries in the subchondral bone stained positive in both cases. Almost all of the
chondrocytes in the tissue fixed on the day of sacrifice stained positive for X-smooth
muscle actin. However, most of these cells appeared to have died (disrupted cytoplasm
and pyknotic nuclei) prior to tissue fixation so further analysis was not performed on
these tissue samples. Virtually none of the chondrocytes in the tissue fixed on the day of
testing stained positive.
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Figure 3.17 - Histological sections of canine articular cartilage from A: an unoperated joint and B: a
harvest-operated joint. Both sections are graded normal (score of 0) on the Mankin scale. Specimens
embedded in JB-4 and stained with Safranin-O/Fast Green.
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CHAPTER 4: DISCUSSION
Although there were no obvious gross changes in the articular cartilage (ie: color
and texture of the tissue appeared normal) distant from the defect or harvest sites of the
operated joints at necropsy (fifteen to eighteen weeks post-operative), there were
significant changes in some of the physical and biochemical properties of the cartilage
when compared to control tissue. Figure 4.1 summarizes the sites at which changes in
physical and biochemical properties were measured. These changes varied in magnitude
(10-300%) and were not wide-spread. Changes in biochemical composition tended to be
less frequent and of smaller magnitude (10-24%) than changes in physical properties (10-
300%). The greatest changes were seen in the dynamic mechanical properties (streaming
potential and dynamic stiffness) of the patellar groove sites taken from the harvest joints.
A B
PP OPP
QDPG L QDPG
ALF A F ALF AD F
QDF QAF
PL PLT T
o 0
C C T C CT
Figure 4.1 - Summary of sites (shaded) at which significant changes (p<0.05) in A: physical properties or
B: biochemical composition were seen for at least one surgical group compared to the unoperated control
group. Note that cartilage at DPG, PLF, and PMF sites was not analyzed for biochemical composition.
The healing of the articular cartilage defects was similar for all three surgical
treatments (Breinan, 1998), yet the articular cartilage throughout the rest of the joint was
affected differently in the different surgical groups. The fewest changes were seen in the
microfracture treated group, with only one property change at one site reaching
significance at p<0.05. The most changes (ten reaching statistical significance) were seen
in the harvest group.
4.1. Comparison of Measured Values with Literature Values
The thickness and equilibrium moduli values measured for the articular cartilage
from the unoperated knees were in general agreement with values found in the literature
for canine articular cartilage. Reported values for thickness range from 1.0 to 1.2 mm for
the tibial plateau, 0.84 to 0.87 mm for the medial condyle, 0.55 to 0.61 mm for the lateral
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condyle, and 0.40 to 0.52 mm for the patellar groove (Arokoski et al., 1996; Athanasiou
et al., 1991; Jurvelin et al., 1987). A similar trend in thickness patterns was observed in
this study. The cartilage was thickest at the central medial tibial plateau (1.4 ± 0.05 mm)
and thinnest at the distal patellar groove (0.50 ± 0.05 mm) and thicker on the medial
femoral condyle (0.72 ± 0.08 mm at AMF) than on the lateral femoral condyle (0.55
0.07 mm at ALF).
Equilibrium moduli calculated in this study tended to be slightly higher than the
values found in the literature although the trends are the same. The cartilage at the distal
patellar groove was stiffer than other sites on the femur and the cartilage on the medial
femoral condyle (2.9 ± 0.5 MPa at AMF) was stiffer than the lateral femoral condyle (1.9
+ 0.1 MPa at PLF). Literature values for Young's modulus range from 0.45 to 1.84 MPa
(Athanasiou et al., 1991; Hale et al., 1993; Jurvelin et al., 1987; Setton et al., 1994). The
equilibrium moduli in this study ranged from 1.9 ± 0.1 MPa at the PLF to 3.7 ± 0.7 MPa
at the distal patellar groove. Although all the values obtained here were higher than most
of the reported values, the modulus reported by Hale, et al. (1.84 MPa; Hale et al., 1993)
was measured by a stress relaxation test similar to the one employed in this study.
It should be emphasized that the focus of this study was on the relative changes of
the articular cartilage from operated versus unoperated joints. Since the site to site trends
reported in other studies were reproduced here, it seems reasonable that the relative
changes seen between surgical groups and the control group are valid.
Additionally, it should be emphasized that previous studies have found that there
are no differences between articular cartilage from the right and left knee joints
(Athanasiou et al., 1991). This allows the comparison of properties measured in
surgically treated (right) knees with those measured in unoperated (left) knees.
4.2. Statistical Validation
There was a wide range in the coefficient of variation for the various mechanical
and biochemical parameters. For the large majority of variables, however, the coefficient
of variation was under 0.5. Although the standard deviation for many cases exceeded the
20% estimation used in the power calculation, the changes in certain properties were also
much greater than the 50% change used in the calculation.
Fisher's exact test was used in addition to the Student's t-test because it is less
affected by a single outlying value when the sample sizes are small. However, for the
majority of the parameters, if significance (p<0.05) was seen by either the Student's t-test
or the Fisher exact test, it was seen by both statistical tests.
4.3. Correlation of Physical and Biochemical Property Changes
Correlations between changes in physical properties and biochemical composition
have been extensively reported (Altman et al., 1984; Armstrong and Mow, 1982;
Buckwalter and Mankin, 1998; Guilak et al., 1994; Hoch et al., 1983; Setton et al.,
1993). For instance, increases in water content have been associated with decreases in
tensile (Guilak et al., 1994) and compressive equilibrium (Altman et al., 1984;
Armstrong et al., 1982; Buckwalter et al., 1998) and dynamic stiffnesses (Hoch et al.,
1983) and increases in tissue permeability (Armstrong et al., 1982; Hoch et al., 1983).
Deviations in tissue stiffness and permeability have also been linked to changes in
proteoglycan content (Buckwalter et al., 1998; Guilak et al., 1994; Hoch et al., 1983). In
this study, however, changes in hydration or GAG content did not accompany changes in
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stiffness (equilibrium or dynamic) and vice versa. For example, the only three sites that
did not show any changes in mechanical properties (up to a significance level of p<O. 10)
were three of the five sites that did show changes (p<0.10) in biochemical properties. It
is possible that our sample size and magnitude of change were too small to detect any
correlations. It is also possible that the changes in mechanical properties at this early
time point are due to tissue reorganization rather than biochemical composition and that
longer-term studies would elucidate correlations between changes in biochemical make-
up and mechanical properties (Setton et al., 1993).
4.4. Relevance of Changes
The changes observed in this study can be summarized as predominantly
increases in streaming potential and dynamic stiffness and both increases and decreases
in cartilage thickness, equilibrium modulus, hydration, GAG content, and DNA content.
4.4.1 Effects of Surgery
Studies have shown that simply opening a joint can induce changes in the
articular cartilage. Biochemical changes associated with arthrotomy include decreased
GAG content and decreased cellular metabolism (Carney et al., 1984; Speer et al., 1990).
The chondrocytes, however, appeared to recover within six weeks of arthrotomy. When
more invasive procedures were performed, the effects were longer-lived. Sams, et al.
(Sams et al., 1995) reported a decrease in GAG content in the articular cartilage within
ten millimeters of surgically created defects compared to normal cartilage four and eight
months after surgery.
It is unlikely, however, that the changes seen in this study can be attributed solely
to the opening of the joint or the creation of the defects. Fewer changes were seen in the
microfracture-treated joints compared to other surgically treated knees. Matrices
implanted alone or seeded with chondrocytes may affect the surrounding cartilage as a
result of the products of matrix degradation or by agents released by the cells in response
to the matrix. The additional trauma of suturing a cover over the implanted matrix may
also affect the cartilage in the joint (Breinan et al., 1997). In analyzing the effects of the
cell-seeded matrix treatment, changes induced by the harvest procedure should also be
considered, as this appeared to induce the most changes to the surrounding cartilage.
Grande, et al., reported that chondral defects that do not penetrate the subchondral bone
appear to progress towards osteoarthritic degeneration (Grande et al., 1989). The defects
created by the harvest procedure are also isolated chondral defects and may also have the
same potential for inducing changes in the surrounding cartilage.
4.4.2 Osteoarthritic Degeneration
Changes believed to be associated with osteoarthritis include increases in water
content (Altman et al., 1984; Buckwalter et al., 1998; Guilak et al., 1994; Mankin, 1974),
and decreases in equilibrium stiffness (Guilak et al., 1994; Hoch et al., 1983), dynamic
stiffness (Hoch et al., 1983), streaming potential (Hoch et al., 1983), and proteoglycan
concentration (Buckwalter et al., 1998; Guilak et al., 1994; Hoch et al., 1983; Mankin,
1974). Although there were a few cases in which the water content increased for the
operated joint relative to control and, hence support the notion of degeneration, the
majority of the significant changes (increases in streaming potential and dynamic
stiffness) are not consistent which osteoarthritis.
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4.4.3 Hypertrophic Remodeling
Prior to cartilage breakdown there is a reparative phase of hypertrophic
remodeling (Brandt, 1993; Buckwalter et al., 1998; Lin et al., 1998). In this phase, as in
the early stages of osteoarthritic degeneration, there are increases in cartilage mass and
cellularity. In contrast to osteoarthritis, however, this phase is further characterized by
increases in proteoglycan concentration (Brandt, 1993; Buckwalter et al., 1998; Lin et
al., 1998) with resulting increases, not decreases, in streaming potential and dynamic
stiffness (Lin et al., 1998). Our observations of increased streaming potential, dynamic
stiffness and DNA content are consistent with this hypertrophic remodeling.
4.5. Clinical Significance
The findings of this study should serve as a warning to clinicians and researchers
investigating methods of articular cartilage repair. Selected procedures can induce
changes in the cartilage of joints subjected to surgical repair of articular cartilage defects.
The magnitude of the changes may depend on the invasiveness and/or complexity of the
procedure. Additionally, the effects of secondary procedures, such as the harvest of
autologous tissue, must be considered when analyzing the potential risk of a given repair
technique. In fact, this study indicates that the harvest procedure yields the greatest
change in the articular cartilage distant to the operated site.
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CHAPTER 5: CONCLUSIONS
The results reported here support the hypothesis that surgical procedures can
affect the physical and biochemical properties of articular cartilage distant to the treated
site. These results represent changes in a canine model fifteen weeks after treatment of
the defects and eighteen weeks after the harvest procedure. It is unclear how or why the
changes in physical and biochemical properties develop and whether or not the changes
seen in this animal model are representative of the human condition. The clinical
significance is also unknown as the changes do not reflect osteoarthritic degeneration but
are consistent with hypertrophic remodeling which may precede later degeneration.
Nonetheless, this work highlights the need for clinicians and researchers to consider the
possible risks cartilage repair procedures on the properties of the articular cartilage
throughout the joint.
Additional studies are necessary to determine the time course of the observed
changes. Future studies may focus on how early the alterations in mechanical and
biochemical properties develop and what specific surgical procedures are more likely to
lead to changes. It is also possible that certain protocols during surgery, such as flushing
of the joint space with enzyme inhibitors will prevent such changes from developing.
Longer-term studies are also needed to investigate if and how the changes progress.
Ultimately, the importance of the findings in this thesis will be determined by whether or
not the changes observed here lead to clinically meaningful problems.
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APPENDICES
APPENDIX A: INDENTATION TESTING PROTOCOL
A.1 Sample Preparation
1. Core 3/8" diameter osteochondral cores from desired locations (use PBS as cooling
fluid) using a standard drill press fitted with a custom-made stainless steel coring bit
(inner diameter 3/8").
2. Freeze cores in PBS until the day of testing
3. Thaw bone-cartilage plugs in PBE (phosphate buffered EDTA, see Appendix B)
4. Mix Quickmount, stirring until just viscous enough to pour (slightly less liquid
component will lead to quicker setting without severely affecting set acrylic)
5. Spray inside of holders with WD-40 and insert cardboard circle
6. Pour Quickmount into holder, filling it 1/2-2/3 full
7. Use tweezers to hold specimen in Quickmount, making sure that cartilage surface is
above Quickmount. Place specimen approximately in the center of holder, trying to
get articular surface parallel to bottom of holder
8. If needed, dispense Quickmount around specimen using a syringe
9. Place PBE soaked gauze over cartilage surface
10. Wait 20-30 minutes for quickmount to completely set
11. Place mounted specimens in bath of PBE and put in 4'C refrigerator until testing (to
minimize storage affects, do not store thawed for more than one test cycle prior to
testing)
A.2 Dynastat Set-up
1. Insert probe and chamber, making sure to tighten collets (small wrench)
2. Attach probe electrode to amplifier (VC 1)
3. Check connections to ADC/DAC box: Lo-R displacement to ADC 0
Load to ADC 1
Streaming Potential Amplifier (bottom-most
connection) to ADC 2
Hi-R Displacement to ADC 3
Streaming Potential Amplifier (VC 2) to DAC 4
Transient to DAC 5
DYN/EXT to Waveform
4. Calibrate load
4.1. Use Coarse/Fine screw to get reading of 0.000
4.2. Push in Cal button and use Gain screw to get 6.415
4.3. Place 1 kg weight on top of load cell and use Gain screw to get 1.000
4.4. Make sure zero suppression set at 018
5. Set B dial to 999, Dyn/Ext dial to 032. Push active button for each. Dial scale to 5.0
6. Calibrate displacement
6.1. Switch toggle to compression
6.2. Put displacement in Lo-R control and Hi-R read
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6.3. Push in Zero button and use Hi-R Zero to get 0.000
6.4. Push in Cal button and use Hi-R Cal to get 4.945
6.5. Put displacement in Hi-R control and Lo-R read
6.6. Push in Zero button and use Lo-R Zero to get 0.000
6.7. Push in Cal button and use Lo-R Cal to get 6.692
6.8. Make sure zero suppression set at 000
7. Put displacement in Lo-R control
8. Set toggle switch to transient
9. Set servo settings: 0 1.0 5.75 5.0 8.3 7.0
10. Set filter settings as follows: High pass 0 0 0
Low pass 1 5 6
Multiplier off
Roll off 0
Mode bandpass
Gain 20dB
Roll off 12dB
Multiplier 10
11. Set amplifier settings as follows: 5 mV
Zero suppression off
Vernier 10.0
Cutoff low DC
Cutoff high 10
A.3 Computer Set-up
1. From c:\cyndi run dynssp
2. Load appropriate protocol (canindent.pro)
3. Enter sample name, thickness and area (0.785 mmA2 for 1 mm indenter probe)
4. Open output file
5. Check to make sure that each control step is right
5.1. Check Acquisition list
5.1.1. First in list is what computer tries to control, so make sure it is
displacement (not Hi-R displacement, except for thickness testing)
5.1.2. Ramp strains should have displacement and load in list
5.1.3. Dynamic strains should have displacement, load and potential in list
5.1.4. Thickness should have Hi-R displacement, load and reference in list
5.2. Check amplitude, control units (strain for stress-relaxations or mm for thickness),
frequency list (dynamic only), return to baseline, max load, samples/sec
6. Check set-up and make sure that load gain is 1Ov/v and that all ADC/DAC
connections correspond to the hook-up of the Dynastat to the computer
A.4 Testing of Samples
1. Insert sample into chamber and adjust to get centered under probe and as close to
parallel as possible. Tighten all screws on chamber
2. Fill chamber with PBE and let equilibrate to swelling pressure 10 min
3. Bring load cell down until get reading of about -0.030V
43
4. Tighten upper collet to fix position of load cell and let equilibrate 5 min.
5. Turn on chart recorder and check set-up
5.1. Banana plugs should be plugged in so that the tab on the side of the plug
corresponds to black
5.2. When switch on zero, the load and displacement pens should be at the right and
the streaming potential pen should be in the middle
5.3. Switch to cal
5.4. Set chart speed to 100 mm/hr
5.5. Set scales to green 5V, red 5V, blue 5V
6. Hit 'g' to start running the protocol
6.1. Ramp to 10% strain (180 seconds) and hold for 320 seconds
6.2. Ramp to 15% strain (180 seconds) and hold for 320 seconds
6.3. Dynamic compression with amplitude of 1% strain at frequencies of 1.0, 0.5, 0.1,
0.05, 0.01, 0.005 Hz (2 cycles at each frequency)
6.4. Ramp to 20% strain (180 seconds) and hold for 320 seconds
A.5 Thickness Measurements
1. When indentation is done, remove probe and insert needle (need to change to the
smaller collet)
2. Let specimen equilibrate, unloaded in PBE for 10 min
3. Switch displacement to Hi-R control
4. Remove some of the PBE from the chamber so that the surface is not submerged
5. Submerge Ag/AgCl electrode in PBE
6. Connect needle as follows: Black alligator to metal strip on needle
Red alligator after resistor and ADC 4
Red plug before resistor and DAC 4
7. Chart recorder (blue, VC14) to ADC 4 (reference)
8. Reconnect chart recorder Lo-R (ADC 0) to Hi-R (ADC 3)
9. Set chart recorder scale to green 50V, red 10 V
10. Hit 'g' to run ramp protocol
10.1. Ramp to 5 mm at rate of 2mm/second
10.2. Electrical circuit is completed when needle probe contacts moist articular
cartilage (top of cartilage)
10.3. Step load (ideally) occurs when needle contacts subchondral bone (bottom of
cartilage)
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BIOCHEMICAL ASSAY PROTOCOLS
B.1 Lyophilization
Samples were lyophilized for 16-24 hours using the Labconco Freeze Dry System.
Temperature set at -60'C. Vacuum pulled to at least 100 gmHg.
B.2 Papain Digestion
Lyophilized tissue was digested overnight (12-24 hours) at 60'C in a 0.125 mg/ml papain
solution:
For 100 ml solution: 90 ml phosphate buffered EDTA (PBE, see below)
0.01M L-cysteine (0.176 g dissolved in 10 ml PBE and sterile
filtered (0.2 gm) into 90ml PBE)
0.5 ml papain (Sigma suspension 25 mg/ml)
PBE stock solution (IL): 0.04M Na 2HPO4 (5.68 g/L)
0.06M NaH2PO 4 *H 2 0 (8.28 g/L)
0.01M Na2EDTA*2H 2 0 (3.72 g/L)
Dissolve above salts in 900 ml distilled water
Adjust pH to 6.5 with IN HCl or IN NaOH
Bring to volume with distilled water
B.3 GAG Assay using dimethylmethylene blue (DMMB) dye
Summary: DMMB dye binds to sulfated glycosaminoglycans and changes color from
blue to purple based on concentration of GAG in solution
Equipment:
Perkin Elmer, Lambda 3B spectrophotometer
Set wavelength to 525 nm
Blank the spec with cuvette (4.5 ml polystyrene cuvette) of air
Protocol:
Run Standards (0, 62.5, 125, 250, 500, 1000, 2000 pg/ml) in triplicate
20 pl standard
2 ml DMMB dye
Blank with 0
Create standard curve (should be quadratic)
Run Samples in duplicate
20 pl sample
2 ml DMMB dye
Determine GAG concentration from standard curve
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APPENDIX B:
Record absorbance readings automatically on computer
GAG standards
0.02 g shark chondroitin 6-sulfate
10 ml PBE
Sterile filter (0.45 gm)
Initial concentration 2000 jg/ml
Serial dilutions in PBE: 1000, 500, 250, 125, 62.5, 0 jg/ml
DMMB dye solution (1 L)
0.016 g 1,9 dimethylmethylene blue dye
5 ml 100% ethanol
Mix in 15 ml centrifuge tube to dissolve (2-3 hours)
2.37 g NaCl
3.04 g glycine
950 ml distilled water
Add dissolved DMB to solution
Rinse tube 2x w/100% EtOH and add wash to solution
8.7 ml 1N HCl
0.2 g sodium azide (toxic!!)
pH to 3.0 with IN HCl
Bring to volume with water
Filter solution through large filter paper
OD reading at 525 nm (4.5 ml cuvette) should be in range 0.20-0.28
Store in brown/amber bottle
Solution stable 3 months
Anything with DMMB dye is ORGANIC WASTE!
B.4 DNA Assay using Hoechst 33258 fluorescent dye
Summary: Bisbenzimidazole fluorescent dye Hoechst 33528 interacts with DNA
dissociated from proteins of the nucleoprotein complex during standard
papain digestion
Equipment:
SPF-550c, SLM Instruments Spectrafluorometer
Excitation wavelength 365 nm
Emission wavelength 458 nm
Excitation bandpass 10 nm
Emission bandpass 5 nm
Reference voltage 445
Reference gain 1
Fluorescence voltage 850
Fluorescence gain 1
Filter 3 seconds
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48 mm acrylic cuvettes (#67.755 Sarstedt, Newton NC)
(for details on use of the spectrometer, ie: how not to burn out very expensive equipment,
see protocol outlined by Andy Loening)
Protocol:
Run standards (0, 0.3125, 0.625, 1.25, 2.5, 5, 10 gg/ml) in triplicate
100 gl standard
2 ml dye
Create standard curve (should be linear)
Run samples in duplicate
100 gl sample
2 ml dye
Determine DNA content from standard curve
Sample/dye complex should reach equilibrium in about 15 seconds and should be stable
for at least 2 hours (less than 5% decrease in fluorescence)
Record emission readings automatically on computer by hitting 'space bar'
DNA standards
1 mg calf thymus DNA
100 ml sterile PBE
Initial concentration 10 gg/ml
Serial dilutions in PBE to 5, 2.5, 1.25, 0.625, 0.3125, 0 gg/ml
DNA dye solution (0.01% Hoechst 33528 dye solution)
450 ml distilled water
50 ml 1Ox TEN buffer
50 gl Hoechst 33258 dye (10000x) (light sensitive; carcinogenic)
cover beaker in tin foil to minimize exposure to light
TEN buffer (1 Ox)
100 mM Tris
10 mM Na2EDTA
1.0 M NaCl
pH 7.5
Anything with Hoechst dye is ORGANIC WASTE!
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APPENDIX C: TISSUE FIXATION AND EMBEDDING
PROTOCOL
C.1 Fixation
Tissue is first fixed in 10% neutral buffered formalin for 5-6 days
C.2 Decalcification
Specimens containing calcified tissue (ie: bone) must be decalcified for at least 28 days.
15% EDTA decalcifying solution:
For 1800 ml: 1570 ml 0.01 M PBS (Sigma #P-3813 dissolved in 1 L distilled water)
44 g NaOH
270 g Disodium Ethylenediamine Tetraacetate (EDTA) (add alternately
with NaOH)
12N HCl to adjust to pH 7.4
C.3 Glycol Methacrylate (JB-4) Embedding
1. Dehydrate using program 9 on Tissue-Tek (1 hour in each alcohol 50%, 60%, 70%,
80%, 90%, 95%, 100%, 100%)
2. Infilitrate specimens twice, 2 days each, in catalyzed solution A (9g catalyst/lL
solution A; JB-4 Embedding kit, Polysciences, Inc., Warrington, PA)
3. Embed in catalyzed solution A - solution B mixture (1 mL solution B/25 mL
catalyzed A)
4. Polymerize overnight at 4'C
5. Remove specimens from molds and store at 40C
C.4 Paraffin Embedding
1. Dehydrate and infiltrate using program 4 on Tissue-Tek (1 hour in each alcohol 50%,
60%, 70%, 80%, 90%, 95%, 100%, 100%, 1 hour each in 2 baths of histoclear and 2
baths of paraffin)
2. Turn on freeze and heat switches on embedder
3. Embed specimens in hot paraffin
4. Allow wax to set (either on cold plate or freezer)
5. Remove from molds and store at 4'C
48
APPENDIX D: HISTOLOGY AND IMMUNOHISTOCHEMISTRY
PROTOCOLS
D.1 Safranin-O Staining
1. Cut JB-4 blocks in 5 gm sections
2. Place slides on hot plate (setting 2) to fix section to slide
3. Stain 30 minutes in Safranin-O (0.2 g Safranin-O, 1 ml acetic acid, 100 ml distilled
water)
4. Rinse with tap water
5. Counter-stain 5 minutes with Fast-Green (0.2 g Fast Green, 1 ml acetic acid, 500 ml
distilled water)
6. Rinse with tap water
7. Allow to air dry
8. Coverslip with permount
D.2 Immunohistochemical Staining for a-Smooth Muscle Actin
1. Cut paraffin blocks in 7 gm sections
2. Place in oven at 50"C overnight
3. Deparaffinze and rehydrate: xylene 2 x 30 minutes
100% EtOH 2 x 1 minute
95% EtOH 1 minute
90% EtOH 1 minute
80% EtOH 1 minute
70% EtOH 1 minute
PBS 3 minutes
4. Wipe of excess liquid and mark around samples with PAP pen (to minimize the
amount of solution needed in the following steps)
5. Trypsin digestion (2-4 drops/sample of 0.01 g trypsin/10 ml PBS) for 60 minutes
6. Wash in PBS 2 x 3 minutes; wipe slides afterwards
7. Hydrogen peroxide (H 20 2) for 5 minutes (2 drops/sample)
8. Wash in PBS 2 x 3 minutes; wipe slides afterwards
9. Block in 30% goat serum for 10 minutes
10. Incubate with primary antibody (1:400 dilution of mouse monoclonal anti-a smooth
muscle actin; Sigma #A2547) or negative control (mouse serum) for 2 hours
11. Wipe slides before wash in PBS 2 x 3 minutes; wipe slides afterwards
12. Incubate with secondary antibody (2 drops/sample of 1:200 dilution of biotintylated
goat anti-mouse immunoglobulin; Sigma #B7151) for 20 minutes
13. Wash in PBS 2 x 3 minutes; wipe slides afterwards
14. Quench in peroxidase (2 drops/sample of 1:50 dilution of ExtraAvidin-Conjugated
Peroxidase; Sigma #E2886)
15. Wash in PBS 2 x 3 minutes; wipe slide afterwards
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16. Stain with a smooth muscle actin immunohistochemical staining kit (4 ml distilled
water, 1 drop 3% H20 2, 2 drops acetate buffer, 1 drop AEC chromagen; kit supplied
by Sigma #IMMH-2) for approximately 10-15 minutes
17. Rinse in distilled water for 3 minutes
18. Counter-stain 20 minutes with Mayer's hematoxylin
19. Rinse in running tap water for 20 minutes
20. Mount with glycerol gelatin and coverslip (must be done in hood); try to avoid air
bubbles
21. Let dry in hood (overnight) and store flat.
Positive staining is indicated by red or red-brown color in the cytoplasm
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APPENDIX E: STATISTICS
In the statistical analysis, the hypothesis tested was that there was no difference in
the mean values between groups. It was also assumed that the groups had equal
variances.
E.1 Power Calculation
A power calculation was performed in order to determine the sample size that
would be necessary to detect significant differences between experimental groups. The
sample size can be calculated as follows:
2( )a, + t2 y)
where: n = sample size
a= standard deviation
8 = difference desired to detect
x = desired significance level (probability of obtaining a false positive result)
P = desired statistical power (probability of obtaining a false negative result)
tav= t statistic corresponding to a significance level x and v degrees of freedom
t 2 v= t statistic corresponding to a significance level 2P and v degrees of freedom
The solutions of this equation for various a, 6, a and P have been tabulated (Orthopedic
Basic Science).
The difference (6) between groups that would be meaningful was assumed to be a
50% change from the mean value of the controls. Based on literature values for canine
articular cartilage thickness and modulus, a standard deviation (a) of 25% was assumed.
Using these values and setting the criteria for significance to be aX=0.05 P=0.2 the sample
size should be four.
E.2 Student's t-test
A two-tailed Student's t-test assuming equal variances and hypothesizing a
difference of 0 was used to determine significance. The t-statistics and corresponding p-
values were calculated using Microsoft Excel based on the following equation:
t 2
CY Pn + m
where: X, X 2 = sample mean
n,m = sample size
UP = pooled variance
2  (rn- 2 +n-i)_s 2
Pm+n-2 1 + n- 2
51
where SpS 2=sample variance
E.3 Fisher Exact Test
A two-tailed Fisher Exact test was also used to determine significance.
Fisher test most often used on 2x2 matrices with small m and n as follows:
The
Group A Group B Row Total
<a w x R,=w+x
>a y z R,=y+z
Column Total C,=w+y C,=x+z N=w+x+y+z
_ (R1 !R2 !)(CI!C 2 !)P . = and
N!(w!x!y!z!)
p -value = 1 (P -- values! P ,.t)
Typically, for the mechanical parameters, the critical value, a, was at least 20%
above or below the average value measured for the unoperated joints. For the
biochemical parameters where the variances were smaller, a was at least 10% above or
below the average value of the unoperated joints.
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